TXMD - TherapeuticsMD, Inc.

2.07
-0.120   -5.797%

Share volume: 32,984
Last Updated: 04-27-2026
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$2.19
-0.12
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
42%
Profitability 25%
Dept financing 28%
Liquidity 75%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.05%
1 Month
4.02%
3 Months
-3.27%
6 Months
65.60%
1 Year
69.67%
2 Year
9.52%
Key data
Stock price
$2.07
P/E Ratio 
41.20
DAY RANGE
$2.04 - $2.20
EPS 
$0.01
52 WEEK RANGE
$0.98 - $2.95
52 WEEK CHANGE
$68.29
MARKET CAP 
12.442 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.60
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$21,283
AVERAGE 30 VOLUME 
$24,117
Company detail
CEO: Mark A. Glickman
Region: US
Website: therapeuticsmd.com
Employees: 420
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone. It also manufactures and distributes branded and generic prescription prenatal vitamins.

Recent news